{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:01:18Z","timestamp":1790766078933,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000272","name":"DH | National Institute for Health Research","doi-asserted-by":"publisher","award":["ACF-2022-17-016"],"award-info":[{"award-number":["ACF-2022-17-016"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"DH | National Institute for Health Research","doi-asserted-by":"publisher","award":["CRF-2016-10023"],"award-info":[{"award-number":["CRF-2016-10023"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"RCUK | Medical Research Council","doi-asserted-by":"publisher","award":["MR\/R005885\/1"],"award-info":[{"award-number":["MR\/R005885\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"RCUK | Medical Research Council","doi-asserted-by":"publisher","award":["MR\/S003444\/1"],"award-info":[{"award-number":["MR\/S003444\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["ZIAMH002857"],"award-info":[{"award-number":["ZIAMH002857"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["NCT00088699"],"award-info":[{"award-number":["NCT00088699"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["04-M-0222"],"award-info":[{"award-number":["04-M-0222"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Activity changes within the anterior cingulate cortex (ACC) are implicated in the antidepressant effects of ketamine, but the ACC is cytoarchitectonically and functionally heterogeneous and ketamine\u2019s effects may be subregion specific. In the context of a double-blind randomized placebo-controlled crossover trial investigating the clinical and resting-state fMRI effects of intravenous ketamine\n                    <jats:italic>vs.<\/jats:italic>\n                    placebo in patients with treatment resistant depression (TRD)\n                    <jats:italic>vs.<\/jats:italic>\n                    healthy volunteers (HV), we used seed-based resting-state functional connectivity (rsFC) analyses to determine differential changes in subgenual ACC (sgACC), perigenual ACC (pgACC) and dorsal ACC (dACC) rsFC two days post-infusion. Across cingulate subregions, ketamine differentially modulated rsFC to the right insula and anterior ventromedial prefrontal cortex, compared to placebo, in TRD\n                    <jats:italic>vs.<\/jats:italic>\n                    HV; changes to pgACC-insula connectivity correlated with improvements in depression scores. Post-hoc analysis of each cingulate subregion separately revealed differential modulation of sgACC-hippocampal, sgACC-vmPFC, pgACC-posterior cingulate, and dACC-supramarginal gyrus connectivity. By comparing rsFC changes following ketamine\n                    <jats:italic>vs.<\/jats:italic>\n                    placebo in the TRD group alone, we found that sgACC rsFC was most substantially modulated by ketamine\n                    <jats:italic>vs.<\/jats:italic>\n                    placebo. Changes to sgACC-pgACC, sgACC-ventral striatal, and sgACC-dACC connectivity correlated with improvements in anhedonia symptoms. This preliminary evidence suggests that accurate segmentation of the ACC is needed to understand the precise effects of ketamine\u2019s antidepressant and anti-anhedonic action.\n                  <\/jats:p>","DOI":"10.1038\/s41398-023-02674-1","type":"journal-article","created":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T07:02:25Z","timestamp":1701414145000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Preliminary evidence that ketamine alters anterior cingulate resting-state functional connectivity in depressed individuals"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1297-6548","authenticated-orcid":false,"given":"Laith","family":"Alexander","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2256-1648","authenticated-orcid":false,"given":"Peter C. T.","family":"Hawkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer W.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1152-5323","authenticated-orcid":false,"given":"Mitul A.","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Carlos A.","family":"Zarate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,1]]},"reference":[{"key":"2674_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2014.105","volume":"4","author":"N Lally","year":"2014","unstructured":"Lally N, Nugent AC, Luckenbaugh DA, Ameli R, Roiser JP, Zarate CA. Anti-anhedonic effect of ketamine and its neural correlates in treatment-resistant bipolar depression. Transl Psychiatry. 2014;4:e469.","journal-title":"Transl Psychiatry"},{"key":"2674_CR2","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1177\/0269881114568041","volume":"29","author":"N Lally","year":"2015","unstructured":"Lally N, Nugent AC, Luckenbaugh DA, Niciu MJ, Roiser JP, Zarate CA. Neural correlates of change in major depressive disorder anhedonia following open-label ketamine. J Psychopharmacol. 2015;29:596\u2013607.","journal-title":"J Psychopharmacol"},{"key":"2674_CR3","doi-asserted-by":"publisher","first-page":"704330","DOI":"10.3389\/fpsyt.2021.704330","volume":"12","author":"A Wilkowska","year":"2021","unstructured":"Wilkowska A, Wiglusz MS, Ga\u0142uszko-Wegielnik M, W\u0142odarczyk A, Cuba\u0142a WJ. Antianhedonic effect of repeated ketamine infusions in patients with treatment resistant depression. Front Psychiatry. 2021;12:704330 (accessed 19 Apr2023) https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2021.704330.","journal-title":"Front Psychiatry"},{"key":"2674_CR4","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.neubiorev.2021.05.003","volume":"127","author":"L Alexander","year":"2021","unstructured":"Alexander L, Jelen LA, Mehta MA, Young AH. The anterior cingulate cortex as a key locus of ketamine\u2019s antidepressant action. Neurosci Biobehav Rev. 2021;127:531\u201354.","journal-title":"Neurosci Biobehav Rev"},{"key":"2674_CR5","doi-asserted-by":"crossref","unstructured":"Vogt BA. Mapping Cingulate Subregions. In: Brain Mapping: An Encyclopaedic Reference. Academic Press, 2015, pp 325-39.","DOI":"10.1016\/B978-0-12-397025-1.00230-X"},{"key":"2674_CR6","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.neuroimage.2007.05.019","volume":"37","author":"DS Margulies","year":"2007","unstructured":"Margulies DS, Kelly AMC, Uddin LQ, Biswal BB, Castellanos FX, Milham MP. Mapping the functional connectivity of anterior cingulate cortex. Neuroimage. 2007;37:579\u201388.","journal-title":"Neuroimage"},{"key":"2674_CR7","doi-asserted-by":"publisher","first-page":"8106","DOI":"10.1073\/pnas.1414728112","volume":"112","author":"M Fuchikami","year":"2015","unstructured":"Fuchikami M, Thomas A, Liu R, Wohleb ES, Land BB, DiLeone RJ, et al. Optogenetic stimulation of infralimbic PFC reproduces ketamine\u2019s rapid and sustained antidepressant actions. Proc Natl Acad Sci USA. 2015;112:8106\u201311.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2674_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2017.7","volume":"7","author":"J Gasull-Cam\u00f3s","year":"2017","unstructured":"Gasull-Cam\u00f3s J, Tarr\u00e9s-Gatius M, Artigas F, Casta\u00f1\u00e9 A. Glial GLT-1 blockade in infralimbic cortex as a new strategy to evoke rapid antidepressant-like effects in rats. Transl Psychiatry. 2017;7:e1038.","journal-title":"Transl Psychiatry"},{"key":"2674_CR9","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s00406-016-0718-1","volume":"267","author":"Y Shirayama","year":"2017","unstructured":"Shirayama Y, Hashimoto K. Effects of a single bilateral infusion of R-ketamine in the rat brain regions of a learned helplessness model of depression. Eur Arch Psychiatry Clin Neurosci. 2017;267:177\u201382.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"2674_CR10","doi-asserted-by":"publisher","first-page":"ENEURO.0025","DOI":"10.1523\/ENEURO.0025-18.2018","volume":"5","author":"SD Dolzani","year":"2018","unstructured":"Dolzani SD, Baratta MV, Moss JM, Leslie NL, Tilden SG, S\u00f8rensen AT, et al. Inhibition of a descending prefrontal circuit prevents ketamine-induced stress resilience in females. eNeuro. 2018;5:ENEURO.0025\u201318.","journal-title":"eNeuro"},{"key":"2674_CR11","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.biopsych.2010.12.015","volume":"69","author":"N Li","year":"2011","unstructured":"Li N, Liu R-J, Dwyer JM, Banasr M, Lee B, Son H, et al. Glutamate NMDA receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure. Biol Psychiatry. 2011;69:754\u201361.","journal-title":"Biol Psychiatry"},{"key":"2674_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2015.136","volume":"5","author":"C Yang","year":"2015","unstructured":"Yang C, Shirayama Y, Zhang J-C, Ren Q, Yao W, Ma M, et al. R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects. Transl Psychiatry. 2015;5:e632.","journal-title":"Transl Psychiatry"},{"key":"2674_CR13","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/j.euroneuro.2016.03.006","volume":"26","author":"D Downey","year":"2016","unstructured":"Downey D, Dutta A, McKie S, Dawson GR, Dourish CT, Craig K, et al. Comparing the actions of lanicemine and ketamine in depression: key role of the anterior cingulate. Eur Neuropsychopharmacol. 2016;26:994\u20131003.","journal-title":"Eur Neuropsychopharmacol"},{"key":"2674_CR14","doi-asserted-by":"publisher","first-page":"109838","DOI":"10.1016\/j.pnpbp.2019.109838","volume":"99","author":"R McMillan","year":"2020","unstructured":"McMillan R, Sumner R, Forsyth A, Campbell D, Malpas G, Maxwell E, et al. Simultaneous EEG\/fMRI recorded during ketamine infusion in patients with major depressive disorder. Prog Neuro-Psychopharmacol Biol Psychiatry. 2020;99:109838.","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"2674_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2015.10","volume":"5","author":"JW Murrough","year":"2015","unstructured":"Murrough JW, Collins KA, Fields J, DeWilde KE, Phillips ML, Mathew SJ, et al. Regulation of neural responses to emotion perception by ketamine in individuals with treatment-resistant major depressive disorder. Transl Psychiatry. 2015;5:e509.","journal-title":"Transl Psychiatry"},{"key":"2674_CR16","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.neubiorev.2017.08.019","volume":"84","author":"H Akil","year":"2018","unstructured":"Akil H, Gordon J, Hen R, Javitch J, Mayberg H, McEwen B, et al. Treatment resistant depression: a multi-scale, systems biology approach. Neurosci Biobehav Rev. 2018;84:272\u201388.","journal-title":"Neurosci Biobehav Rev"},{"key":"2674_CR17","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.neuron.2018.11.021","volume":"101","author":"L Alexander","year":"2019","unstructured":"Alexander L, Gaskin PLR, Sawiak SJ, Fryer TD, Hong YT, Cockcroft GJ, et al. Fractionating blunted reward processing characteristic of anhedonia by over-activating primate subgenual anterior cingulate cortex. Neuron. 2019;101:307\u201320.e6.","journal-title":"Neuron"},{"key":"2674_CR18","doi-asserted-by":"publisher","first-page":"eade1779","DOI":"10.1126\/scitranslmed.ade1779","volume":"15","author":"CM Wood","year":"2023","unstructured":"Wood CM, Alexander L, Alsi\u00f6 J, Santangelo AM, McIver L, Cockcroft GJ, et al. Chemogenetics identifies separate area 25 brain circuits involved in anhedonia and anxiety in marmosets. Sci Transl Med. 2023;15:eade1779.","journal-title":"Sci Transl Med"},{"key":"2674_CR19","first-page":"1","volume":"26","author":"A Mkrtchian","year":"2020","unstructured":"Mkrtchian A, Evans JW, Kraus C, Yuan P, Kadriu B, Nugent AC, et al. Ketamine modulates fronto-striatal circuitry in depressed and healthy individuals. Mol Psychiatry. 2020;26:1\u201310.","journal-title":"Mol Psychiatry"},{"key":"2674_CR20","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1038\/s41386-019-0591-5","volume":"45","author":"LS Morris","year":"2020","unstructured":"Morris LS, Costi S, Tan A, Stern ER, Charney DS, Murrough JW. Ketamine normalizes subgenual cingulate cortex hyper-activity in depression. Neuropsychopharmacology. 2020;45:975\u201381.","journal-title":"Neuropsychopharmacology"},{"key":"2674_CR21","doi-asserted-by":"publisher","first-page":"105000","DOI":"10.1016\/j.neubiorev.2022.105000","volume":"145","author":"AFT Arnsten","year":"2023","unstructured":"Arnsten AFT, Joyce MKP, Roberts AC. The Aversive Lens: stress effects on the prefrontal-cingulate cortical pathways that regulate emotion. Neurosci Biobehav Rev. 2023;145:105000.","journal-title":"Neurosci Biobehav Rev"},{"key":"2674_CR22","doi-asserted-by":"publisher","first-page":"8306","DOI":"10.1523\/JNEUROSCI.0860-20.2020","volume":"40","author":"MKP Joyce","year":"2020","unstructured":"Joyce MKP, Garc\u00eda-Cabezas M\u00c1, John YJ, Barbas H. Serial prefrontal pathways are positioned to balance cognition and emotion in primates. J Neurosci. 2020;40:8306\u201328.","journal-title":"J Neurosci"},{"key":"2674_CR23","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.biopsych.2011.11.022","volume":"72","author":"EB Ansell","year":"2012","unstructured":"Ansell EB, Rando K, Tuit K, Guarnaccia J, Sinha R. Cumulative adversity and smaller gray matter volume in medial prefrontal, anterior cingulate, and insula regions. Biol Psychiatry. 2012;72:57\u201364.","journal-title":"Biol Psychiatry"},{"key":"2674_CR24","doi-asserted-by":"publisher","first-page":"3684","DOI":"10.1038\/s41380-020-00973-3","volume":"26","author":"AFT Arnsten","year":"2021","unstructured":"Arnsten AFT, Datta D, Wang M. The genie in the bottle-magnified calcium signaling in dorsolateral prefrontal cortex. Mol Psychiatry. 2021;26:3684\u2013700.","journal-title":"Mol Psychiatry"},{"key":"2674_CR25","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.biopsych.2020.05.033","volume":"90","author":"RFH Cash","year":"2021","unstructured":"Cash RFH, Weigand A, Zalesky A, Siddiqi SH, Downar J, Fitzgerald PB, et al. Using brain imaging to improve spatial targeting of transcranial magnetic stimulation for depression. Biol Psychiatry. 2021;90:689\u2013700.","journal-title":"Biol Psychiatry"},{"key":"2674_CR26","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.biopsych.2018.01.027","volume":"84","author":"JW Evans","year":"2018","unstructured":"Evans JW, Szczepanik J, Brutsch\u00e9 N, Park LT, Nugent AC, Zarate CA. Default mode connectivity in major depressive disorder measured up to 10 days after ketamine administration. Biol Psychiatry. 2018;84:582\u201390.","journal-title":"Biol Psychiatry"},{"key":"2674_CR27","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1038\/s41380-018-0028-2","volume":"24","author":"AC Nugent","year":"2019","unstructured":"Nugent AC, Ballard ED, Gould TD, Park LT, Moaddel R, Brutsche NE, et al. Ketamine has distinct electrophysiological and behavioral effects in depressed and healthy subjects. Mol Psychiatry. 2019;24:1040\u201352.","journal-title":"Mol Psychiatry"},{"key":"2674_CR28","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1192\/bjp.134.4.382","volume":"134","author":"SA Montgomery","year":"1979","unstructured":"Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382\u20139.","journal-title":"Br J Psychiatry"},{"key":"2674_CR29","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1192\/bjp.167.1.99","volume":"167","author":"RP Snaith","year":"1995","unstructured":"Snaith RP, Hamilton M, Morley S, Humayan A, Hargreaves D, Trigwell P. A scale for the assessment of hedonic tone the Snaith-Hamilton Pleasure Scale. Br J Psychiatry. 1995;167:99\u2013103.","journal-title":"Br J Psychiatry"},{"key":"2674_CR30","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/j.jrp.2005.11.001","volume":"40","author":"DE Gard","year":"2006","unstructured":"Gard DE, Gard MG, Kring AM, John OP. Anticipatory and consummatory components of the experience of pleasure: a scale development study. J Res Personal. 2006;40:1086\u2013102.","journal-title":"J Res Personal"},{"key":"2674_CR31","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.jad.2012.03.024","volume":"141","author":"S K\u00fchn","year":"2012","unstructured":"K\u00fchn S, Vanderhasselt M-A, De Raedt R, Gallinat J. Why ruminators won\u2019t stop: the structural and resting state correlates of rumination and its relation to depression. J Affect Disord. 2012;141:352\u201360.","journal-title":"J Affect Disord"},{"key":"2674_CR32","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1006\/cbmr.1996.0014","volume":"29","author":"RW Cox","year":"1996","unstructured":"Cox RW. AFNI: software for analysis and visualization of functional magnetic resonance neuroimages. Comput Biomed Res. 1996;29:162\u201373.","journal-title":"Comput Biomed Res"},{"key":"2674_CR33","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1089\/brain.2013.0154","volume":"3","author":"PA Taylor","year":"2013","unstructured":"Taylor PA, Saad ZS. FATCAT: (an efficient) functional and tractographic connectivity analysis toolbox. Brain Connect. 2013;3:523\u201335.","journal-title":"Brain Connect"},{"key":"2674_CR34","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.neuroimage.2013.01.047","volume":"73","author":"G Chen","year":"2013","unstructured":"Chen G, Saad ZS, Britton JC, Pine DS, Cox RW. Linear mixed-effects modeling approach to FMRI group analysis. Neuroimage. 2013;73:176\u201390.","journal-title":"Neuroimage"},{"key":"2674_CR35","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/nn.2303","volume":"12","author":"N Kriegeskorte","year":"2009","unstructured":"Kriegeskorte N, Simmons WK, Bellgowan PSF, Baker CI. Circular analysis in systems neuroscience: the dangers of double dipping. Nat Neurosci. 2009;12:535\u201340.","journal-title":"Nat Neurosci"},{"key":"2674_CR36","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1523\/JNEUROSCI.2363-17.2017","volume":"38","author":"MKP Joyce","year":"2018","unstructured":"Joyce MKP, Barbas H. Cortical connections position primate area 25 as a keystone for interoception, emotion, and memory. J Neurosci. 2018;38:1677\u201398.","journal-title":"J Neurosci"},{"key":"2674_CR37","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1017\/S1092852900013754","volume":"13","author":"WC Drevets","year":"2008","unstructured":"Drevets WC, Savitz J, Trimble M. The subgenual anterior cingulate cortex in mood disorders. CNS Spectr. 2008;13:663\u201381.","journal-title":"CNS Spectr"},{"key":"2674_CR38","doi-asserted-by":"publisher","first-page":"12320","DOI":"10.1073\/pnas.231475998","volume":"98","author":"RM Sapolsky","year":"2001","unstructured":"Sapolsky RM. Depression, antidepressants, and the shrinking hippocampus. Proc Natl Acad Sci USA. 2001;98:12320\u20132.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2674_CR39","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1038\/mp.2015.176","volume":"21","author":"FR Carreno","year":"2016","unstructured":"Carreno FR, Donegan JJ, Boley AM, Shah A, DeGuzman M, Frazer A, et al. Activation of a ventral hippocampus-medial prefrontal cortex pathway is both necessary and sufficient for an antidepressant response to ketamine. Mol Psychiatry. 2016;21:1298\u2013308.","journal-title":"Mol Psychiatry"},{"key":"2674_CR40","first-page":"1157","volume":"238","author":"JS Siegel","year":"2021","unstructured":"Siegel JS, Palanca BJA, Ances BM, Kharasch ED, Schweiger JA, Yingling MD, et al. Prolonged ketamine infusion modulates limbic connectivity and induces sustained remission of treatment-resistant depression. Psychopharmacology. 2021;238:1157\u201369.","journal-title":"Psychopharmacology"},{"key":"2674_CR41","doi-asserted-by":"publisher","first-page":"e1710","DOI":"10.7717\/peerj.1710","volume":"4","author":"JJ Wong","year":"2016","unstructured":"Wong JJ, O\u2019Daly O, Mehta MA, Young AH, Stone JM. Ketamine modulates subgenual cingulate connectivity with the memory-related neural circuit-a mechanism of relevance to resistant depression? PeerJ. 2016;4:e1710.","journal-title":"PeerJ"},{"key":"2674_CR42","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/nrn3027","volume":"12","author":"SG Disner","year":"2011","unstructured":"Disner SG, Beevers CG, Haigh EAP, Beck AT. Neural mechanisms of the cognitive model of depression. Nat Rev Neurosci. 2011;12:467\u201377.","journal-title":"Nat Rev Neurosci"},{"key":"2674_CR43","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/j.neuron.2014.04.042","volume":"82","author":"S Duvarci","year":"2014","unstructured":"Duvarci S, Pare D. Amygdala microcircuits controlling learned fear. Neuron. 2014;82:966\u201380.","journal-title":"Neuron"},{"key":"2674_CR44","doi-asserted-by":"publisher","first-page":"114123","DOI":"10.1016\/j.psychres.2021.114123","volume":"304","author":"A Pisoni","year":"2021","unstructured":"Pisoni A, Davis SW, Smoski M. Neural signatures of saliency-mapping in anhedonia: A narrative review. Psychiatry Res. 2021;304:114123.","journal-title":"Psychiatry Res"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-023-02674-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-023-02674-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-023-02674-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T07:03:08Z","timestamp":1701414188000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-023-02674-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,1]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2674"],"URL":"https:\/\/doi.org\/10.1038\/s41398-023-02674-1","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,1]]},"assertion":[{"value":"28 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"CAZ is listed as a co-inventor on a patent for the use of ketamine in major depression and suicidal ideation; as a co-inventor on a patent for the use of (2\u2009R,6\u2009R)-hydroxynorketamine, (S)-dehydronorketamine, and other stereoisomeric dehydro and hydroxylated metabolites of (R,S)-ketamine metabolites in the treatment of depression and neuropathic pain; and as a co-inventor on a patent application for the use of (2\u2009R,6\u2009R)-hydroxynorketamine and (2\u2009S,6\u2009S)-hydroxynorketamine in the treatment of depression, anxiety, anhedonia, suicidal ideation, and post-traumatic stress disorders. He has assigned his patent rights to the U.S. government but will share a percentage of any royalties that may be received by the government. All other authors have no conflict of interest to disclose, financial or otherwise.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"371"}}